Top Tweets for #biotechdev18
How do you de-risk #drugdevelopment, utilise more predictive models and add value to your drug asset? @Christopher Boyer presented some of our thinking at the recent #biotechdev18 event. https://t.co/LnFe0EQNBE
“De-risking preclinical assets with early human insights; recent advances in human tissue and disease models”: Christopher Boyer’s presentation for BioMelbourne Network’s #biotechdev18 is now available to view at our website: https://t.co/J5vl3ZX4rL.
And that’s a wrap! Thanks to @biomelb & @dr_krystal for a fantastic event today, it’s been a blast! #biotechdev18
$2.6 trillion superannuation industry has a taste to invest in the #biotech sector - Darren Schultz, CFO, ISPT #biotechdev18
Very impressive panel @biomelb with Penelope Lane, Rosemary Addis, A/Assoc. Prof. Helen Woods, Helen Fischer and Darren Schultz. #biotechdev18
I love a good success story, especially one that comes out of Swan Hill, Victoria! #biotechdev18 @MedicinesDev Well done. @biomelb
Learning about push pull incentives for drug development and commercialisation in orphan diseases from Dr Danielle Smith, Medicines Development for Global Health #biotechdev18
Another big pharma player here at the @biomelb event - Michael Haberl, Head of Reimbursement & Pricing at @GSK_AU talking about global payer trends for pharma and their impact on development programs #biotechdev18
Key insights: choosing the right time to spin-out, who will lead the new spin-out (scientific founder or other?), being capital raising ready and balancing resources - @HughAlsop, CEO @Kinoxis_Tx #biotechdev18
Our CEO @Djk70 describing use of patient advocacy groups and molecular pathway analysis to run better clinical trials #biotechdev18
There's a lot of talk about collaboration, but nothing has felt more like being part of a team than joining a #biotech company - Fantastic career insight from Dr Sara Prickett #biotechdev18
Definitely hearing a common theme today - Sara Prickett, COO Aravax, also notes the importance of sourcing the appropriate #expertise: “You don’t know what you don’t know” #biotechdev18
Spin-out superstar Darren Kelly (@Djk70) providing insight into the Certa Therapeutics journey #biotechdev18
Gearing up for part two of the Biotech Development Lab - thanks to @biomelb @DEDJTR @WatermarkIP @SeerPharma and @PrimeFinGrp for hosting and sponsoring! #biotechdev18
Regulators are no longer just gatekeepers but enablers in drug development. - Adj. Prof. John Skerrit #biotechdev18 @TGAgovau
When the govt asked if Australia needs its own #regulatory body, it was unanimously agreed yes, especially if we want to develop the #biotech industry in Australia - John Skerritt, @TGAgovau #biotechdev18
What’s new from the TGA. See slide below - Adj. Prof. John Skerrit #biotechdev18
Awesome to hear that @BioCurate is looking to support the broader #biotech ecosystem @unimelb @MonashUni #biotechdev18
“Acknowledge the depth of science in academia” - Trevor Perrior #biotechdev18
Most Popular Users
Elon Musk 
@elonmusk
241M followers
Barack Obama
@barackobama
119.2M followers
Cristiano Ronaldo
@cristiano
112.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.1M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.3M followers
KATY PERRY
@katyperry
88.6M followers
Taylor Swift
@taylorswift13
82.5M followers
Lady Gaga
@ladygaga
74M followers
Virat Kohli
@imvkohli
71.3M followers
Kim Kardashian
@kimkardashian
70.2M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.4M followers
Neymar Jr
@neymarjr
64.2M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.7M followers
X
@x
60.8M followers